This absence of a further decline in GFR indicates that COL4A1 renal disease is unlikely to progress to renal failure, which is supported by a limited reduction of GFR in humans with HANAC syndrome (Plaisier et al., 2007). This evidence concerns the gene COL4A1 and kidney failure.